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eriprocedural Myocardial Injury:
ot a Benign Entity
rasad et al. (1) present valuable insights into the prognostic
nfluence of spontaneous myocardial infarction (SMI) and peripro-
edural myocardial infarction (PMI) following stent insertion in
he ACUITY (Acute Catheterization and Urgent Intervention
riage Strategy) trial. They concluded that PMI is of limited
rognostic significance as it is predominantly a marker for procedural
nd baseline risk factors, and that, in contrast to SMI, it does not
ave independent prognostic significance. Given the differences in
he pathophysiology, it is unsurprising that PMI and SMI have
ifferential influence on prognosis at 1 year, but we wish to
uestion some of the investigators’ interpretation of their data, as
e feel that the significance of PMI has been understated.
Their principal conclusion about the lack of prognostic influ-
nce is based on the 1-year mortality hazard ratio for PMI being
ound to be not significant after adjustment for procedural and
aseline characteristics. In this study, both PMI (3.2% vs. 0.8%,
 0.0001) and SMI (5.0% vs. 0.8%, p  0.0001) are associated
ith higher 30-day mortality without any significant difference
etween the 2 types of myocardial infarction (p 0.27). No hazard
atio for 30-day mortality after the time-updated covariate-
djusted multivariate analysis is quoted, but the Kaplan-Meier
raphs show similar curves for SMI and PMI in the early
ost-procedural period, suggesting that both types of myocardial
nfarction predict an adverse short-term outcome. Interestingly,
tent thrombosis in patients that sustained PMI appears to have a
orse prognosis than SMI without stent thrombosis.
The relevance of periprocedural enzyme elevation has been the
opic of considerable debate, but it is increasingly clear that even
mall periprocedural troponin rises reflect new areas of myocardial
ecrosis on magnetic resonance imaging (2,3). Debate persists
bout the influence on prognosis of these small/moderate enzyme
ises, but there is little doubt about the influence of large
eriprocedural enzyme rises—even in this study, the 1-year mor-
ality for Q-wave PMI is extremely high at 27%, versus 17.3% for
-wave SMI (p  0.22).
Previous studies from patients undergoing nonemergency per-
utaneous coronary intervention, whether using creatine kinase-
yocardial band or troponin definitions of PMI, have shown that
MI is an adverse long-term prognosticator (4–6). It is notable in
his study of patients with acute coronary syndromes that a nefinition combining new elevation of 3 creatine phosphoki-
ase or creatine kinase-myocardial band and electrocardiography
riteria has been used for PMI. Troponin, a more sensitive and
pecific biomarker, is not used for the diagnosis of PMI but is used
or the diagnosis of SMI.
We agree that PMI and SMI are different entities, and
nevitably SMI would portend a worse prognosis. However, we feel
hat PMI with imaging evidence of myocardial necrosis represents
n adverse event with long-term outcome implications. The
ong-term consequences of minor periprocedural enzyme rises are
ore uncertain and need more investigation, especially with the
dvent of the new universal definition of PMI using a troponin
utoff of 3 the 99th percentile (7).
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eply
e thank Dr. Lim and colleagues for their interest in our paper
1). While agreeing with the principal finding of our study (1) that
pontaneous myocardial infarction (SMI) portends a worse prog-
osis than periprocedural myocardial infarction (PMI), Lim and
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February 2, 2010:499–506olleagues remain concerned that we have underestimated the
mportance of PMI. We agree with many of the suppositions in
heir communication (as clearly stated throughout our report [1]),
amely that “even small periprocedural troponin rises reflect new
reas of myocardial necrosis on MRI imaging,” and “there is little
oubt about the influence of large periprocedural enzyme rises . . . .”
e disagree, however, that “debate persists about the influence on
rognosis of these small/moderate enzyme rises . . . .” Whereas the
iterature is replete with prior studies examining the influence of
MI, the largest studies in the stent era have shown that only truly
arge PMI as evidenced by elevation of peak creatine kinase-
yocardial band to 8 or 10 normal or the development of
ew Q-waves significantly influences subsequent survival (2,3).
ther studies that have used a low threshold for PMI have found
hat such infarctions have no long-term prognostic significance (4).
maller enzyme elevations are a marker for more diffuse athero-
clerosis (5), but do not have per se a great enough influence on left
entricular function or arrhythmogenesis to directly impair sur-
ival. Other studies have suggested that biomarker elevations after
ercutaneous coronary intervention are of no clinical relevance
nless associated with a failed procedure or angiographic compli-
ations (6). We also agree with Dr. Lim and colleagues that the
rognostic implications of troponin elevations after percutaneous
oronary intervention are uncertain, with questionable clinical
elevance (7).
The data from the ACUITY (Acute Catheterization and
rgent Intervention Triage Strategy) trial are consistent with these
revious studies; when considering all PMI (defined as creatine
inase-myocardial band 3 normal, the most widely used
efinition) in a time-updated, covariate-adjusted multivariable
odel, PMI was not an independent correlate of 1-year survival.
owever, large PMI (such as Q-wave myocardial infarction), was
predictor. Our study was not meant to minimize the role of large
MI, which clearly reduce early and late survival. Rather, most
mall PMI may be disregarded as clinically inconsequential,
hereas SMI, even using a sensitive threshold for detection (any
roponin elevation greater than the local laboratory normal), is a
owerful independent predictor of subsequent mortality. These
ata emphasize the fact that SMI and PMI deserve different
hresholds for diagnosis and should prompt suitably different
herapeutic responses.
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ortic Stiffness in
ypertrophic Cardiomyopathy
n the paper by Boonyasirinant et al. (1) in a recent issue of the
ournal, there are serious problems in the use of pulse wave velocity
PWV) data as an index of aortic stiffness in hypertrophic
ardiomyopathy (HCM).
The major technical problem is that whereas magnetic reso-
ance imaging (MRI) can measure dimensions accurately, it can
nly measure flow at intervals of around 30 ms (Fig. 1 from
oonyasirinant et al. [1]), so that PWV, as distance travelled
ivided by time between wave feet, is likely to be less accurate,
specially over very short distances (typically 12 to 13 cm in this
eport [1]) than when measured invasively or noninvasively by high
delity manometry (2,3). This may account for unusually high
ariability of PWV measurements, especially in the HCM groups.
The most curious issue in this MRI report (1) is that normal
ubjects had lower values of aortic PWV (3.7 m/s, SD 0.9 m/s)
han previously published for any normal group using invasive
r noninvasive techniques (2,3). A previous MRI study (4) in
ormal (but obese) subjects of similar age gave PWV values of
.8 m/s (SD 2.2 m/s), which is similar to that reported for
CM patients in the recent MRI report (1). Further, normal
ubjects (Fig. 5 from Boonyasirinant et al. [1]) had a blunted
ave foot for the distal aortic wave, which is quite different
rom normal flow and pressure waves, from which PWV is
sually calculated. High variability of PWV in HCM (mean
.66 m/s, SD 6.43 m/s in 1 group and 6.51 m/s, SD 3.2 m/s in
nother) is not correctly represented in Figure 2 of Boonyasiri-
ant et al. (1), nor are the confidence intervals, whose long
whiskers” do not appear at all. Data in the text and legend of Figure
(1) do not correspond to that shown in the figure.
These issues ought to be considered before the confident assertions
f Boonyasirinant et al. (1) or Kuhl (5) are accepted that the MRI
echnique reveals “novel insights in vascular function from MRI” (1)
r “an unidentified association unraveled by MRI” (5).
